Analystreport

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is now covered by analysts at Maxim Group. They set a "buy" rating and a $24.00 price target on the stock.

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com